AUA
Audeara Limited
🇦🇺 ASX
🛍️ CONSUMER
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-21.54%
Annual Growth
3 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
3
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Audeara Ltd. engages in the development of noise-cancelling consumer headphones. The company is headquartered in Fortitude Valley, Queensland. The company went IPO on 2021-05-18. The firm specializes in listening solutions for people with hearing challenges. Its principal activity is development of hearing health technology. Its headphones deliver personalized audio to users via Bluetooth headphones. Its headphones are categorized as an assistive listening device (ALD), which can be paired with its mobile application called the Audeara App. Its technology is compatible for use with cochlear implants and hearing aids. The Audeara App uses a personalized algorithm to calibrate the headphones for an individual’s hearing profile. This provides clear sound quality for video conferencing and telephone calls and using mainstream applications like watching television, listening to music, and gaming. Its products include A-01 Headphones, BT-01 Transceiver, A-02 Headphones and A-02 TV Bundle. The company sells its products through distributors and resellers in Australia and North America, and via e-commerce channels.
📈 Performance
Price History
-72.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.06
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in AUA
3
📊 Total Capital Earnings
$-312.726
🔃 Average investment frequency
38 weeks
💵 Average investment amount
$350
⏰ Last time a customer invested in AUA
31 days
AUA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50%
50k - 100k
50%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
67%
35 - 90
33%
🙋 Legal gender of investors
Female
33%
Male
67%
Pearlers who invest in AUA also invest in...
CLNE.AX was created on 2021-03-08 by VanEck. The fund's investment portfolio concentrates primarily on theme equity. Each Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
📊 Share price
$6.19 AUD
🔋 UTILITIES
🇦🇺 EX AUSTRALIA
IMPQ.AX was created on 2021-09-29 by Perennial. The fund's investment portfolio concentrates primarily on total market equity. The objective of the Fund is to deliver long-term capital growth predominately through investments in Australian and New Zealand listed smaller and mid-cap companies that are Better Future Investments.
🙌 Performance (5Yr p.a)
3.56%
📊 Share price
$5.03 AUD
💸 FINANCIALS
🇺🇸 EX UNITED STATES
ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)
🙌 Performance (5Yr p.a)
3.96%
📊 Share price
$71.16 AUD
🇦🇺 EX AUSTRALIA
🩺 HEALTH CARE
🤖 TECHNOLOGY
🏭 INDUSTRIALS
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
🙌 Performance (5Yr p.a)
10.36%
📊 Share price
$35.32 AUD
📈 HIGH PRICE GROWTH
🇦🇺 EX AUSTRALIA
🤖 TECHNOLOGY
🩺 HEALTH CARE
CNEW.AX was created on 2018-11-08 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. CNEW.AX gives investors a portfolio of the most fundamentally sound companies in China having the best growth prospects in sectors making up the New Economy, namely technology, health care, consumer staples and consumer discretionary. CNEW.AX aims to provide investment returns, before fees and other costs, which track the performance of the Index.
🙌 Performance (5Yr p.a)
-4.90%
📊 Share price
$5.18 AUD
🌏 ASIA
🩺 HEALTH CARE
🛍️ CONSUMER
🇨🇳 CHINA
🤖 TECHNOLOGY
Want more shares? Try these...
AUB Group Ltd.Provides equity based insurance broker network.It operates under the following segments: Australian Broking, New Zealand, Australian Agencies, and Support Service. The company is headquartered in Sydney, New South Wales and currently employs 2,433 full-time employees. The company went IPO on 2005-11-16. Its segments include Australian Broking, New Zealand Broking, Agencies, Tysers and Support service. The Australian Broking segment assesses the insurable risks and risk appetite of customers and sources relevant insurance products from insurers and underwriters which meet the needs of the customer. The Agencies segment assesses, on behalf of the insurer, the risk profile of the end customer and pricing of policies requested by brokers. The New Zealand Broking segment provides broking services within the New Zealand market. The Tysers segment includes wholesale and retail broking and managing general agents. The Support Services segment provides a range of services to support the Australian Broking, Agencies, and New Zealand Broking and Tysers segments, and external clients. Retail broking provides retail broking services within the United Kingdom market.
🙌 Performance (5Yr p.a)
38.11%
📊 Share price
$31.13 AUD
📈 HIGH PRICE GROWTH
👩💼 INSURANCE
Ausgold Ltd. engages in mineral exploration and resource development. The company is headquartered in Perth, Western Australia. The company went IPO on 2009-12-16. The Company’s flagship project is the Katanning Gold Project, located approximately 275 kilometers (km) south-east of Perth and approximately 40km north-east of the wheatbelt town of Katanning. The tenements cover over 5,500 square kilometers (km2) of the Katanning Greenstone Belt in the south-west corner of the Yilgarn Craton, which hosts some of Australia’s gold deposits. Its portfolio also includes the Doolgunna Station Cu-Au project and the Yamarna Ni-Cu-Co project in Western Australia and the Cracow Au Project in Queensland. The Doolgunna Station Project is located over 150 km north-east of Meekatharra in Western Australia’s Bryah Basin and approximately 13km to the west of, and along trend from, Sandfire Resources’ Degrussa copper-gold operation. The Yamarna Project is located approximately 125 km north-east of Laverton in central Western Australia on Exploration Licenses E38/2129 and ELA 38/3311.
🙌 Performance (5Yr p.a)
432.63%
📊 Share price
$0.43 AUD
⛏️ MINING
Amplia Therapeutics Ltd. is a medical biotechnology company, which engages in the development of drugs for potential use in multiple indications including oncology and chronic fibrosis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2013-12-23. The firm is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The firm's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The firm's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.
🙌 Performance (5Yr p.a)
5.01%
📊 Share price
$0.10 AUD
🧬 BIOTECHNOLOGY
The Agency Group Australia Ltd. engages in providing real estate and financial services. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-12-18. The Company’s principal activity consists of real estate services and related activities. The company segments include Real Estate Property Services and Mortgage Origination Services. Its Real Estate and Property Services segment is engaged in the provision of real estate services including selling of property, settlement agent services, and property management. Its Mortgage Origination Services segment is engaged in the provision of mortgage broking services. The firm's wholly owned subsidiaries include Agency Partners WA Pty Ltd, Ausnet Financial Planning Services Pty Ltd, Ausnet Financial Pty Ltd, Ausnet Property Investment Fund Pty Ltd, Ausnet Real Estate Services Pty Ltd, Bushby & Co. Pty Ltd, Jelina Holdings Pty Ltd, Move Property Solutions Pty Ltd, The Agency Auctions NSW Pty Ltd, The Agency Canberra Pty Ltd, The Agency Commercial Real Estate Pty Ltd, and The Agency Marketing Pty Ltd.
🙌 Performance (5Yr p.a)
-13.73%
📊 Share price
$0.02 AUD
🏠 REAL ESTATE